LFTD Partners Inc. LSFP OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

46/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

LFTD Partners Inc. (LSFP) generated $1.32T in operating cash flow for fiscal year 2025. After capital expenditures of $121.64B, free cash flow was $1.2T.

Free cash flow margin was 3.2% of revenue. Cash conversion ratio was -0.05x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (83/100, Pass) — demonstrate the company can comfortably service its debt
MOAT (52/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
INCOME (10/100) — Cash conversion ratio was -0.05x suggests some earnings are non-cash items

Overall SharesGrow Score: 43/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

46/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✓

HEALTH

83/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

52/100

Proven by this page

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

LFTD Partners Inc. Cash Flow History

Metric	TTM	FY2025	FY2024	FY2021	FY2020
Operating Cash Flow	$969.75B	$1.32T	$-960.07K	$5.62M	$-338.04K
Capital Expenditure	$-44.49B	$-121.64B	$-313.76K	$-368.22K	$-70.13K
Free Cash Flow	$925.26B	$1.2T	$-1.27M	$5.25M	$-408.17K